| 000 | 01619 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515224450.0 | ||
| 264 | 0 | _c20100816 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/1471-2407-10-237 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernardini, Marcus Q | |
| 245 | 0 | 0 |
_aExpression signatures of TP53 mutations in serous ovarian cancers. _h[electronic resource] |
| 260 |
_bBMC cancer _cMay 2010 |
||
| 300 |
_a237 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSurvivors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aBaba, Tsukasa | |
| 700 | 1 | _aLee, Paula S | |
| 700 | 1 | _aBarnett, Jason C | |
| 700 | 1 | _aSfakianos, Gregory P | |
| 700 | 1 | _aSecord, Angeles Alvarez | |
| 700 | 1 | _aMurphy, Susan K | |
| 700 | 1 | _aIversen, Edwin | |
| 700 | 1 | _aMarks, Jeffrey R | |
| 700 | 1 | _aBerchuck, Andrew | |
| 773 | 0 |
_tBMC cancer _gvol. 10 _gp. 237 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-10-237 _zAvailable from publisher's website |
| 999 |
_c19856843 _d19856843 |
||